NKTR logo

Nektar Therapeutics (NKTR) Total Debt

Annual Total Debt

$117.78 M
-$13.72 M-10.43%

31 December 2023

NKTR Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Debt

$108.26 M
-$3.84 M-3.42%

30 September 2024

NKTR Quarterly Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NKTR Total Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-10.4%-10.7%
3 y3 years-21.6%-26.1%
5 y5 years-52.3%-73.1%

NKTR Total Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-21.6%at low-26.1%at low
5 y5 years-71.1%at low-73.7%at low
alltimeall time-73.1%>+9999.0%-75.3%>+9999.0%

Nektar Therapeutics Total Debt History

DateAnnualQuarterly
Sept 2024
-
$108.26 M(-3.4%)
June 2024
-
$112.10 M(-1.7%)
Mar 2024
-
$114.08 M(-3.1%)
Dec 2023
$117.78 M(-10.4%)
$117.78 M(-2.9%)
Sept 2023
-
$121.29 M(-2.8%)
June 2023
-
$124.75 M(-2.7%)
Mar 2023
-
$128.16 M(-2.5%)
Dec 2022
$131.50 M(-8.2%)
$131.50 M(-2.3%)
Sept 2022
-
$134.65 M(-3.4%)
June 2022
-
$139.46 M(-1.9%)
Mar 2022
-
$142.24 M(-0.7%)
Dec 2021
$143.18 M(-4.7%)
$143.18 M(-2.2%)
Sept 2021
-
$146.46 M(-1.3%)
June 2021
-
$148.43 M(-1.3%)
Mar 2021
-
$150.32 M(+0.0%)
Dec 2020
$150.29 M(-63.2%)
$150.29 M(-2.6%)
Sept 2020
-
$154.37 M(-1.5%)
June 2020
-
$156.77 M(-62.0%)
Mar 2020
-
$412.05 M(+1.0%)
Dec 2019
$408.14 M(+65.3%)
$408.14 M(+1.4%)
Sept 2019
-
$402.67 M(+16.2%)
June 2019
-
$346.39 M(+0.7%)
Mar 2019
-
$344.06 M(+39.3%)
Dec 2018
$246.95 M(+0.7%)
$246.95 M(+0.2%)
Sept 2018
-
$246.51 M(+0.2%)
June 2018
-
$246.08 M(+0.2%)
Mar 2018
-
$245.64 M(+0.2%)
Dec 2017
$245.21 M(+0.7%)
$245.21 M(-0.8%)
Sept 2017
-
$247.25 M(-0.3%)
June 2017
-
$248.10 M(-0.1%)
Mar 2017
-
$248.42 M(+2.0%)
Dec 2016
$243.46 M(-1.6%)
$243.46 M(-1.6%)
Sept 2016
-
$247.52 M(-0.6%)
June 2016
-
$248.94 M(-0.5%)
Mar 2016
-
$250.24 M(+1.1%)
Dec 2015
$247.53 M(+85.2%)
$247.53 M(+87.2%)
Sept 2015
-
$132.22 M(-1.0%)
June 2015
-
$133.53 M(-0.9%)
Mar 2015
-
$134.80 M(+0.9%)
Dec 2014
$133.65 M(-2.1%)
$133.65 M(+2.5%)
Sept 2014
-
$130.34 M(-0.5%)
June 2014
-
$131.03 M(-0.8%)
Mar 2014
-
$132.05 M(-3.3%)
Dec 2013
$136.59 M(-0.0%)
$136.59 M(+1.9%)
Sept 2013
-
$134.01 M(-0.7%)
June 2013
-
$134.90 M(-0.6%)
Mar 2013
-
$135.77 M(-0.6%)
Dec 2012
$136.61 M(-40.5%)
$136.61 M(-0.6%)
Sept 2012
-
$137.41 M(-39.8%)
June 2012
-
$228.13 M(-0.3%)
Mar 2012
-
$228.84 M(-0.3%)
Dec 2011
$229.54 M(-1.0%)
$229.54 M(-0.3%)
Sept 2011
-
$230.21 M(-0.3%)
June 2011
-
$230.82 M(-0.3%)
Mar 2011
-
$231.40 M(-0.2%)
Dec 2010
$231.97 M(-0.8%)
$231.97 M(-0.2%)
Sept 2010
-
$232.36 M(-0.2%)
June 2010
-
$232.84 M(-0.2%)
Mar 2010
-
$233.31 M(-0.2%)
Dec 2009
$233.75 M
$233.75 M(-0.2%)
Sept 2009
-
$234.18 M(-0.2%)
DateAnnualQuarterly
June 2009
-
$234.57 M(-0.2%)
Mar 2009
-
$234.94 M(-0.2%)
Dec 2008
$235.30 M(-30.1%)
$235.30 M(-30.2%)
Sept 2008
-
$337.09 M(-0.2%)
June 2008
-
$337.85 M(-0.2%)
Mar 2008
-
$338.59 M(+0.6%)
Dec 2007
$336.63 M(-23.2%)
$336.63 M(-16.8%)
Sept 2007
-
$404.75 M(+0.7%)
June 2007
-
$401.77 M(-0.0%)
Mar 2007
-
$401.94 M(-8.3%)
Dec 2006
$438.12 M(-0.1%)
$438.12 M(+0.0%)
Sept 2006
-
$438.07 M(-0.0%)
June 2006
-
$438.19 M(-0.0%)
Mar 2006
-
$438.30 M(-0.0%)
Dec 2005
$438.41 M(+120.2%)
$438.41 M(-0.0%)
Sept 2005
-
$438.52 M(+125.0%)
June 2005
-
$194.89 M(-0.7%)
Mar 2005
-
$196.30 M(-1.4%)
Dec 2004
$199.06 M(-49.4%)
$199.06 M(-0.1%)
Sept 2004
-
$199.35 M(-3.2%)
June 2004
-
$205.89 M(-4.0%)
Mar 2004
-
$214.52 M(-45.5%)
Dec 2003
$393.30 M(+18.5%)
$393.30 M(-7.5%)
Sept 2003
-
$424.98 M(+3.5%)
June 2003
-
$410.81 M(+23.9%)
Mar 2003
-
$331.70 M(-0.1%)
Dec 2002
$332.02 M(+0.0%)
$332.02 M(-0.1%)
Sept 2002
-
$332.45 M(+0.2%)
June 2002
-
$331.86 M(+0.1%)
Mar 2002
-
$331.68 M(-0.1%)
Dec 2001
$331.87 M(+3.6%)
$331.87 M(+0.6%)
Sept 2001
-
$329.74 M(+1.0%)
June 2001
-
$326.46 M(+2.4%)
Mar 2001
-
$318.92 M(-0.4%)
Dec 2000
$320.29 M(+182.5%)
$320.29 M(+32.0%)
Sept 2000
-
$242.63 M(-0.0%)
June 2000
-
$242.64 M(-0.8%)
Mar 2000
-
$244.65 M(+115.8%)
Dec 1999
$113.39 M(+2166.0%)
$113.39 M(+2212.2%)
Sept 1999
-
$4.90 M(-0.3%)
June 1999
-
$4.92 M(-0.2%)
Mar 1999
-
$4.92 M(-1.6%)
Dec 1998
$5.00 M(-3.5%)
$5.00 M(+0.9%)
Sept 1998
-
$4.96 M(-0.3%)
June 1998
-
$4.97 M(-2.2%)
Mar 1998
-
$5.09 M(-1.9%)
Dec 1997
$5.18 M(+1196.3%)
$5.18 M(+3403.4%)
Sept 1997
-
$148.00 K(-8.6%)
June 1997
-
$162.00 K(-7.4%)
Mar 1997
-
$175.00 K(-56.3%)
Dec 1996
$400.00 K(-33.3%)
$400.00 K(+100.0%)
Sept 1996
-
$200.00 K(-33.3%)
June 1996
-
$300.00 K(0.0%)
Mar 1996
-
$300.00 K(-50.0%)
Dec 1995
$600.00 K(-14.3%)
$600.00 K(+100.0%)
Sept 1995
-
$300.00 K(0.0%)
June 1995
-
$300.00 K(-25.0%)
Mar 1995
-
$400.00 K(-42.9%)
Dec 1994
$700.00 K
$700.00 K(+250.0%)
Sept 1994
-
$200.00 K(-75.0%)
June 1994
-
$800.00 K(0.0%)
Mar 1994
-
$800.00 K

FAQ

  • What is Nektar Therapeutics annual total debt?
  • What is the all time high annual total debt for Nektar Therapeutics?
  • What is Nektar Therapeutics annual total debt year-on-year change?
  • What is Nektar Therapeutics quarterly total debt?
  • What is the all time high quarterly total debt for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly total debt year-on-year change?

What is Nektar Therapeutics annual total debt?

The current annual total debt of NKTR is $117.78 M

What is the all time high annual total debt for Nektar Therapeutics?

Nektar Therapeutics all-time high annual total debt is $438.41 M

What is Nektar Therapeutics annual total debt year-on-year change?

Over the past year, NKTR annual total debt has changed by -$13.72 M (-10.43%)

What is Nektar Therapeutics quarterly total debt?

The current quarterly total debt of NKTR is $108.26 M

What is the all time high quarterly total debt for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly total debt is $438.52 M

What is Nektar Therapeutics quarterly total debt year-on-year change?

Over the past year, NKTR quarterly total debt has changed by -$13.03 M (-10.74%)